Status:
COMPLETED
Platelet Activity in Vascular Surgery for Thrombosis and Bleeding
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
American Heart Association
Conditions:
Peripheral Vascular Disease
Peripheral Artery Disease
Eligibility:
All Genders
21+ years
Brief Summary
The proposed PIVOTAL study will examine a panel of platelet/coagulation activity markers during the perioperative period. The goal is to develop a clinically useful assessment of platelet/coagulation ...
Detailed Description
To describe platelet activity among PAD subjects undergoing vascular surgery. To determine whether preoperative platelet activity measurements are independently associated with perioperative cardiova...
Eligibility Criteria
Inclusion
- Subjects undergoing non emergent vascular surgery
- Use of aspirin within 48 hours prior to surgery
- Age \> 21 years of age
- Able and willing to provide written informed consent for the study
Exclusion
- Use of any anticoagulant (Coumadin, heparin) within 24 hours to surgery
- Use of any Nonsteroidal Antiinflammatory Drug (NSAID) (such as ibuprofen, naproxen, etc.) within 72 hours
- Thrombocytopenia (platelet count\<100) or Thrombocytosis (platelet count\>500),
- Anemia (hemoglobin\<9),
- Severe kidney disease (CrCl\<30ml/min),
- Any known hemorrhagic diathesis.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01897103
Start Date
June 1 2013
End Date
December 1 2017
Last Update
December 14 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bellevue Hospital Center, South Manhattan Healthcare Network
New York, New York, United States, 10016
2
New York University School Of Medicine
New York, New York, United States, 10016